Matches in SemOpenAlex for { <https://semopenalex.org/work/W2143257003> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W2143257003 endingPage "349" @default.
- W2143257003 startingPage "342" @default.
- W2143257003 abstract "Phosphodiesterase type 5 (PDE5) inhibitors are, today, the first treatment option for erectile dysfunction (ED). However, efficacy does not exceed 70%, while the drop-out rate is high. Therefore, salvage strategies and second/third line treatment options are necessary to restore erectile response in such patients. This literature review of the currently available data on non-responders to PDE5 inhibitors aims to discuss key issues that physicians address in everyday clinical practice. These issues include the definition of treatment failure, the identification of factors that affect treatment outcome and the management strategy for non-responders to PDE5 inhibitors. Medication, clinical and patient/partner related issues have been identified as factors related to treatment failure. Treatment outcome assessment is based not only on quality of erectile response, but also on side effect profiles and patient satisfaction. Proper instructions for PDE5 inhibitor administration and psychosexual counselling may convert a substantial number of non-responders to responders. Inappropriate use of PDE5 inhibitors is a major issue in clinical practice. Non-responders may be converted to responders after careful assessment of the proper use of a PDE5 inhibitor. Treatment options for true non-responders are under investigation and include chronic administration of PDE5 inhibitors (everyday, low dose use), switchover from one drug to another or combination treatments. Management strategies must identify patient and partner needs and expectations and involve them in the decision-making." @default.
- W2143257003 created "2016-06-24" @default.
- W2143257003 creator A5077941636 @default.
- W2143257003 date "2006-12-01" @default.
- W2143257003 modified "2023-09-26" @default.
- W2143257003 title "Non-responders to phosphodiesterase type 5 inhibitors: is there a second chance?" @default.
- W2143257003 cites W1522545453 @default.
- W2143257003 cites W1832887128 @default.
- W2143257003 cites W1966373063 @default.
- W2143257003 cites W1968298168 @default.
- W2143257003 cites W1971555927 @default.
- W2143257003 cites W1971833377 @default.
- W2143257003 cites W1987747940 @default.
- W2143257003 cites W1990669420 @default.
- W2143257003 cites W1992231535 @default.
- W2143257003 cites W1994273184 @default.
- W2143257003 cites W2006456016 @default.
- W2143257003 cites W2024876112 @default.
- W2143257003 cites W2034246651 @default.
- W2143257003 cites W2035351306 @default.
- W2143257003 cites W2043590202 @default.
- W2143257003 cites W2044741772 @default.
- W2143257003 cites W2052518051 @default.
- W2143257003 cites W2056125033 @default.
- W2143257003 cites W2060344709 @default.
- W2143257003 cites W2072069294 @default.
- W2143257003 cites W2076357493 @default.
- W2143257003 cites W2082980601 @default.
- W2143257003 cites W2084697763 @default.
- W2143257003 cites W2087975822 @default.
- W2143257003 cites W2088130312 @default.
- W2143257003 cites W2091416414 @default.
- W2143257003 cites W2091636911 @default.
- W2143257003 cites W2093349952 @default.
- W2143257003 cites W2094546458 @default.
- W2143257003 cites W2099385242 @default.
- W2143257003 cites W2110688148 @default.
- W2143257003 cites W2121881032 @default.
- W2143257003 cites W2121939064 @default.
- W2143257003 cites W2124968539 @default.
- W2143257003 cites W22857079 @default.
- W2143257003 cites W2297358297 @default.
- W2143257003 cites W2313556008 @default.
- W2143257003 cites W2315299098 @default.
- W2143257003 cites W2327417095 @default.
- W2143257003 cites W4253316705 @default.
- W2143257003 doi "https://doi.org/10.1016/j.jmhg.2006.08.007" @default.
- W2143257003 hasPublicationYear "2006" @default.
- W2143257003 type Work @default.
- W2143257003 sameAs 2143257003 @default.
- W2143257003 citedByCount "7" @default.
- W2143257003 countsByYear W21432570032013 @default.
- W2143257003 countsByYear W21432570032014 @default.
- W2143257003 countsByYear W21432570032015 @default.
- W2143257003 countsByYear W21432570032019 @default.
- W2143257003 countsByYear W21432570032021 @default.
- W2143257003 crossrefType "journal-article" @default.
- W2143257003 hasAuthorship W2143257003A5077941636 @default.
- W2143257003 hasConcept C126322002 @default.
- W2143257003 hasConcept C141071460 @default.
- W2143257003 hasConcept C177713679 @default.
- W2143257003 hasConcept C2775944032 @default.
- W2143257003 hasConcept C2779929075 @default.
- W2143257003 hasConcept C71924100 @default.
- W2143257003 hasConcept C74534348 @default.
- W2143257003 hasConceptScore W2143257003C126322002 @default.
- W2143257003 hasConceptScore W2143257003C141071460 @default.
- W2143257003 hasConceptScore W2143257003C177713679 @default.
- W2143257003 hasConceptScore W2143257003C2775944032 @default.
- W2143257003 hasConceptScore W2143257003C2779929075 @default.
- W2143257003 hasConceptScore W2143257003C71924100 @default.
- W2143257003 hasConceptScore W2143257003C74534348 @default.
- W2143257003 hasIssue "4" @default.
- W2143257003 hasLocation W21432570031 @default.
- W2143257003 hasOpenAccess W2143257003 @default.
- W2143257003 hasPrimaryLocation W21432570031 @default.
- W2143257003 hasRelatedWork W1959489784 @default.
- W2143257003 hasRelatedWork W2034812448 @default.
- W2143257003 hasRelatedWork W2040925013 @default.
- W2143257003 hasRelatedWork W2062517715 @default.
- W2143257003 hasRelatedWork W2080246620 @default.
- W2143257003 hasRelatedWork W2134025139 @default.
- W2143257003 hasRelatedWork W2363006105 @default.
- W2143257003 hasRelatedWork W4323565927 @default.
- W2143257003 hasRelatedWork W4323648505 @default.
- W2143257003 hasRelatedWork W2604586985 @default.
- W2143257003 hasVolume "3" @default.
- W2143257003 isParatext "false" @default.
- W2143257003 isRetracted "false" @default.
- W2143257003 magId "2143257003" @default.
- W2143257003 workType "article" @default.